Crisponi syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1545OMIM:272430G90.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Crisponi syndrome, also known as cold-induced sweating syndrome type 1 (CISS1), is an extremely rare autosomal recessive disorder caused by mutations in the CRLF1 (cytokine receptor-like factor 1) gene on chromosome 19p13. It was first described in Sardinian families and primarily affects the autonomic nervous system, musculoskeletal system, and thermoregulatory mechanisms. The condition is characterized by neonatal onset of distinctive facial features, muscular contractions of facial muscles resembling trismus (jaw clenching) triggered by tactile stimulation, feeding difficulties, hyperthermia, and episodes of unexplained high fever. Affected infants often display camptodactyly (flexion contractures of the fingers), broad nose, full cheeks, and a characteristic pursed-lip facial appearance. In the neonatal period, Crisponi syndrome carries a high mortality risk, primarily due to hyperthermia and respiratory complications. Infants who survive the critical neonatal period may develop a phenotype that overlaps significantly with cold-induced sweating syndrome (CISS), characterized by profuse sweating of the face and upper body in response to cold temperatures, progressive scoliosis, and feeding difficulties. The trismus and muscular contractions typically improve with age in surviving patients. There is currently no specific or curative treatment for Crisponi syndrome. Management is supportive and symptomatic, focusing on careful thermoregulation, nutritional support (often requiring nasogastric or gastrostomy tube feeding), monitoring and management of respiratory complications, and physical therapy for musculoskeletal manifestations. Antipyretic measures and environmental temperature control are critical in the neonatal period. Genetic counseling is recommended for affected families. The recognition that Crisponi syndrome and cold-induced sweating syndrome represent a clinical continuum caused by CRLF1 mutations has improved understanding and long-term prognostication for affected individuals.

Clinical phenotype terms— hover any for plain English:

Malignant hyperthermiaHP:0002047
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Crisponi syndrome.

View clinical trials →

No actively recruiting trials found for Crisponi syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Crisponi syndrome community →

No specialists are currently listed for Crisponi syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Crisponi syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Crisponi syndromeForum →

No community posts yet. Be the first to share your experience with Crisponi syndrome.

Start the conversation →

Latest news about Crisponi syndrome

No recent news articles for Crisponi syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Crisponi syndrome

What is Crisponi syndrome?

Crisponi syndrome, also known as cold-induced sweating syndrome type 1 (CISS1), is an extremely rare autosomal recessive disorder caused by mutations in the CRLF1 (cytokine receptor-like factor 1) gene on chromosome 19p13. It was first described in Sardinian families and primarily affects the autonomic nervous system, musculoskeletal system, and thermoregulatory mechanisms. The condition is characterized by neonatal onset of distinctive facial features, muscular contractions of facial muscles resembling trismus (jaw clenching) triggered by tactile stimulation, feeding difficulties, hyperthermi

How is Crisponi syndrome inherited?

Crisponi syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Crisponi syndrome typically begin?

Typical onset of Crisponi syndrome is neonatal. Age of onset can vary across affected individuals.